glp-1 news past 3 days GLP-1 obesity drugs and eating disorders are not well understood yet : NPR New oral GLP-1 drug delivers

Fong and our team of Cleanbody nutritionists, who will collaborate with you to craft a tailored nutrition regimen that suits your unique needs and goals

They were sued in August 2023 by a Louisiana woman Jaclyn Bjorklund, who alleged the companies downplayed the severity of the gastrointestinal events caused by Ozempic and Mounjaro, and in particular played down the risk of gastroparesis, which is the slowing or stopping of the digestive system

For obesity treatment, it is not covered by insurance and is self-pay

Side effects span from mild (nausea, flushing) to serious, and fake or contaminated products are a genuine hazard

doi: 10.3389/fphar.2017.00592

You may notice less GI discomfort around meals, though individual responses vary.*